Laura F Hutchins Selected Research

Laura F Hutchins Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2002
15	Neoplasms (Cancer) 01/2023 - 03/2003
11	Melanoma (Melanoma, Malignant) 01/2021 - 04/2007
3	Pathologic Complete Response 01/2017 - 02/2015
2	Ductal Carcinoma 01/2016 - 02/2015
2	Neoplasm Metastasis (Metastasis) 01/2016 - 04/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2015 - 06/2005
2	Sarcoma (Soft Tissue Sarcoma) 06/2015 - 02/2002
1	Exanthema (Rash) 01/2021
1	Colitis 01/2016
1	Pancreatitis 01/2016
1	Diarrhea 01/2016
1	Uterine Cervical Dysplasia 10/2015
1	Thrombotic Thrombocytopenic Purpura 02/2015
1	Merkel Cell Carcinoma 01/2014
1	Neutropenia 11/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 07/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2010
1	Brain Neoplasms (Brain Tumor) 01/2010
1	Bone Diseases (Bone Disease) 07/2008
1	Osteoporosis 07/2008
1	Vitamin D Deficiency 07/2008

Drug/Important Bio-Agent (IBA)

7	Hormones (Hormone)IBA 01/2023 - 01/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2005
5	Tamoxifen FDA LinkGeneric 04/2008 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2005
3	IpilimumabIBA 01/2021 - 01/2016
3	CarbohydratesIBA 01/2020 - 04/2007
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 01/2005
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2005
3	Bevacizumab (Avastin)FDA Link 01/2017 - 02/2015
2	InterferonsIBA 01/2021 - 11/2007
2	VaccinesIBA 01/2020 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	AntigensIBA 01/2020 - 04/2007
2	Peptides (Polypeptides)IBA 01/2020 - 10/2015
2	AntibodiesIBA 11/2017 - 04/2007
2	Protein Subunit VaccinesIBA 11/2017 - 04/2007
2	Monoclonal AntibodiesIBA 01/2016 - 01/2016
2	EnzymesIBA 11/2010 - 03/2003
2	Thalidomide (Thalomid)FDA Link 01/2010 - 11/2007
2	AnthracyclinesIBA 03/2008 - 02/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	peptide AIBA 01/2020
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2020
1	Melanins (Melanin)IBA 12/2019
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 11/2017
1	CTLA-4 AntigenIBA 07/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Histones (Histone)IBA 01/2016
1	Histone MethyltransferasesIBA 01/2016
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2016
1	Polycomb Repressive Complex 2IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 10/2015
1	Vaccine AdjuvantsIBA 10/2015
1	pazopanib FDA Link 06/2015
1	thiamine triphosphorate (TTP)IBA 02/2015
1	Rituximab (Mabthera)FDA Link 02/2015
1	ADAMTS13 ProteinIBA 02/2015
1	Factor VIII (Coagulation Factor VIII)IBA 02/2015
1	Estrogen ReceptorsIBA 02/2015
1	von Willebrand FactorIBA 02/2015
1	VemurafenibIBA 04/2014
1	Genetic Markers (Genetic Marker)IBA 12/2010
1	AntioxidantsIBA 11/2010
1	Superoxide DismutaseIBA 11/2010
1	Temozolomide (Temodar)FDA LinkGeneric 01/2010
1	Dacarbazine (DIC)FDA LinkGeneric 01/2010
1	NRH - quinone oxidoreductase2IBA 08/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2009
1	Vitamin D FDA LinkGeneric 07/2008
1	Diphosphonates (Bisphosphonates)IBA 07/2008
1	CalciumIBA 07/2008
1	exemestane (Aromasin)FDA Link 04/2008
1	Dihydrotachysterol (AT 10)IBA 03/2008
1	Cytidine Monophosphate (CMP)IBA 04/2007
1	Immunoglobulin M (IgM)IBA 04/2007
1	Cytostatic AgentsIBA 01/2005
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2003

Therapy/Procedure

11	Therapeutics 01/2020 - 11/2002
7	Drug Therapy (Chemotherapy) 01/2020 - 02/2007
3	Radiotherapy 01/2023 - 01/2005
3	Adjuvant Chemotherapy 01/2019 - 03/2008
3	Neoadjuvant Therapy 01/2017 - 04/2011
3	Aftercare (After-Treatment) 12/2014 - 03/2003
2	Segmental Mastectomy (Lumpectomy) 01/2023 - 01/2005
1	Lasers (Laser) 12/2019
1	Terminal Care (Care, Terminal) 07/2018
1	Immunotherapy 07/2017
1	Plasma Exchange 02/2015
1	Radical Mastectomy 04/2011
1	Treatment Delay 05/2009
1	Secondary Prevention 05/2009
1	Nephrectomy 06/2005
1	Combination Drug Therapy (Combination Chemotherapy) 03/2003